ITMI20000972A0 - Formulazioni farmaceutiche, a rilascio modificato, con elevata biodisponibilita', contenenti principi attivi ad attivita' antibiotica. - Google Patents

Formulazioni farmaceutiche, a rilascio modificato, con elevata biodisponibilita', contenenti principi attivi ad attivita' antibiotica.

Info

Publication number
ITMI20000972A0
ITMI20000972A0 IT2000MI000972A ITMI20000972A ITMI20000972A0 IT MI20000972 A0 ITMI20000972 A0 IT MI20000972A0 IT 2000MI000972 A IT2000MI000972 A IT 2000MI000972A IT MI20000972 A ITMI20000972 A IT MI20000972A IT MI20000972 A0 ITMI20000972 A0 IT MI20000972A0
Authority
IT
Italy
Prior art keywords
active ingredients
pharmaceutical formulations
modified release
containing active
antibiotic activity
Prior art date
Application number
IT2000MI000972A
Other languages
English (en)
Inventor
Ubaldo Conte
Lauretta Maggo
Original Assignee
Italiano Biochimico Far Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Italiano Biochimico Far Lab filed Critical Italiano Biochimico Far Lab
Priority to IT2000MI000972A priority Critical patent/IT1318495B1/it
Publication of ITMI20000972A0 publication Critical patent/ITMI20000972A0/it
Priority to EP01110735A priority patent/EP1151747A1/en
Publication of ITMI20000972A1 publication Critical patent/ITMI20000972A1/it
Application granted granted Critical
Publication of IT1318495B1 publication Critical patent/IT1318495B1/it

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IT2000MI000972A 2000-05-04 2000-05-04 Formulazioni farmaceutiche, a rilascio modificato, con elevatabiodisponibilita', contenenti principi attivi ad attivita' IT1318495B1 (it)

Priority Applications (2)

Application Number Priority Date Filing Date Title
IT2000MI000972A IT1318495B1 (it) 2000-05-04 2000-05-04 Formulazioni farmaceutiche, a rilascio modificato, con elevatabiodisponibilita', contenenti principi attivi ad attivita'
EP01110735A EP1151747A1 (en) 2000-05-04 2001-05-03 Modified release pharmaceutical formulations containing active principles having antibiotic activity

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT2000MI000972A IT1318495B1 (it) 2000-05-04 2000-05-04 Formulazioni farmaceutiche, a rilascio modificato, con elevatabiodisponibilita', contenenti principi attivi ad attivita'

Publications (3)

Publication Number Publication Date
ITMI20000972A0 true ITMI20000972A0 (it) 2000-05-04
ITMI20000972A1 ITMI20000972A1 (it) 2001-11-04
IT1318495B1 IT1318495B1 (it) 2003-08-25

Family

ID=11444968

Family Applications (1)

Application Number Title Priority Date Filing Date
IT2000MI000972A IT1318495B1 (it) 2000-05-04 2000-05-04 Formulazioni farmaceutiche, a rilascio modificato, con elevatabiodisponibilita', contenenti principi attivi ad attivita'

Country Status (2)

Country Link
EP (1) EP1151747A1 (it)
IT (1) IT1318495B1 (it)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6124516A (ja) * 1984-07-12 1986-02-03 Fujisawa Pharmaceut Co Ltd 持続性錠剤
US4968508A (en) * 1987-02-27 1990-11-06 Eli Lilly And Company Sustained release matrix
US5948440A (en) * 1997-12-17 1999-09-07 Ranbaxy Laboratories Limited Modified release matrix formulation of cefaclor and cephalexin
KR100296413B1 (ko) * 1998-04-01 2001-11-14 김선진 세파클러함유서방성정제

Also Published As

Publication number Publication date
EP1151747A1 (en) 2001-11-07
ITMI20000972A1 (it) 2001-11-04
IT1318495B1 (it) 2003-08-25

Similar Documents

Publication Publication Date Title
HUP0400566A3 (en) Pharmaceutical preparation comprising an active dispersed on a matrix
ITMI20001173A0 (it) Composizioni farmaceutiche a rilascio prolungato per la somministrazione parenterale di sostanze idrofile biologicamente attiva.
JP2002511411A5 (it)
NO20016107D0 (no) Mesalazin-kontrollert frigivelse orale farmasöytiske sammensetninger
ITTO20010005A1 (it) Formulazione farmaceutica.
PT1220856E (pt) Compostos farmaceuticamente activos
TR200003787A3 (tr) Kararli yavas salimli oral dozaj bilesimi.
ATE320799T1 (de) Retardierte, orale, pharmazeutische darreichnungsformen mit tramadol
TR199901077A3 (tr) Ispençiyari formülasyonlar.
KR970006279A (ko) 약제학적 활성 성분으로서의 6-디메틸아미노메틸-1-페닐-사이클로헥산 화합물
ATE259798T1 (de) Pharmazeutisch aktive verbindungen
ATE406885T1 (de) Nateglinid enthaltende präparate
AU2001234114A1 (en) Drugs containing combined active ingredients
DK1733725T4 (da) Farmaceutiske formuleringer omfattende mindst én HIV-proteaseinhiberende forbindelse
ATE252377T1 (de) Kontrolliert freisetzende pharmazeutische zusammensetzung mit tilidinmesylat als wirkstoff
ITMI20021725A1 (it) Composizioni farmaceutiche ad attivita' antibiotica.
HK1046501A1 (en) Pharmaceutical agent comprising a benzamide derivative as active ingredient.
HUP0303860A3 (en) A pharmaceutical tablet having a high active ingredient
ZA200304928B (en) Medicament containing a polyamine as an active substance.
PT1200444E (pt) Novos compostos xantona, sua preparacao e sua utilizacao como medicamento
EE200200391A (et) Farmatseutiline kompositsioon, mis sisaldab hüdrokarbüültuumaga ühendit
ITMI20000972A0 (it) Formulazioni farmaceutiche, a rilascio modificato, con elevata biodisponibilita', contenenti principi attivi ad attivita' antibiotica.
ITMI20001848A0 (it) Faramaci per l'incontinenza.
AU2001260089A1 (en) Pharmaceutical compositions comprising desglymidodrine as an active drug substance
MA26677A1 (fr) Medicaments antiparkinsoniens.